Sinovac Biotech from China seeks co-financing for COVID-19 vaccine trial in Bangladesh

▴ chinese-vaccine-company-sinovac-biotech-seeks-cofinancing-covid19-vaccine-trial-in-bangladesh
The Chinese vaccine company Sinovac Biotech has sought co-financing from Bangladesh for a phase-3 clinical trial of its COVID-19 vaccine

The Chinese vaccine company Sinovac Biotech has sought co-financing from Bangladesh for a phase-3 clinical trial of its COVID-19 vaccine.

The company was given permission to carry out the phase-3 human trial about a month back by the government.

Responding to an unconfirmed report about the Chinese company asking for co-financing for a vaccine trial, the Health Division Secretary of the government of Bangladesh Abdul Mannan confirmed to the official news agency BSS yesterday that Sinovac Biotech Ltd has sent a letter to the government seeking co-financing for COVID 19 vaccine trial.

He said that the company had not asked for co-financing by the Bangladesh government when it obtained the approval to carry out the trial.

The Chinese company had originally put up the proposal to Bangladesh through the Dhaka based International Centre for Diarrheal Disease Research, Bangladesh (ICDDR’B). The government granted final clearance for the clinical trial on August 27.

An official of the ICDDR’B told BSS that it is now entirely up to the government to decide if they will agree to the co-financing proposal as there was no mention of it in the original proposal of the Chinese company.

Under the agreement before the co-financing was sought, Bangladesh would have got one lakh vaccines for free. It would also have got priority to purchase adequate quantum of vaccines from the Chinese company Sinovac Biotech.

Meanwhile, Bangladesh Govt has issued directives restricting certain activities in view of the security, law and order and COVID-19 pandemic during the upcoming Durga Puja in the country. The directives came after the meeting Chaired by Home Minister Asaduzzamn Khan on Sunday in Dhaka.

The meeting requested the leaders of the nationwide Sarbajanin Puja Committee to limit the number of Puja mandaps as much as possible. The government has also decided that no procession will be allowed during the immersion of the idol at the end of the Durga Puja, said the press release issued by the Home Ministry.

The meeting decided that the Puja Celebration Committee will take steps to reduce the number of public gatherings at the Puja Mandap and to broadcast the Anjali program live. The organisers have been asked to maintain health guidelines such as social distancing, wearing of masks and using the hand sanitiser for people visiting the mandaps.

Police forces will be on mobile duty to deal with law and order situations. The guidelines also require that various ceremonies should be held maintaining religious harmony. The Puja Udjapan Committee will be coordinating with the local administration and law enforcement agencies for the management of the mandaps.

Tags : #SinivacBiotech #China #Bangladesh #COVID-19Vaccine #Phase-3Trial #LatestPharmaNews5thOct #LatestCOVIDNews5thOct

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

10 Strategies to counter disinformation for the healthcare digital ecosystemApril 23, 2024
Is Selling Over-the-Counter (OTC) Drugs in General Stores A Step Towards Affordable Healthcare in IndiaApril 23, 2024
Student Health Crisis: Food Poisoning Incident Strikes Pune Coaching CentreApril 23, 2024
The Impact of Diabetes on Kidney Health: Diabetic Nephropathy ExplainedApril 23, 2024
Toddler Hospitalized After Consuming Expired Chocolates: Health Concerns RaisedApril 23, 2024
After months of diagnostic delay, a migrant worker could access TB services only when a community health worker met himApril 22, 2024
Indian Spices Contaminated with Cancer-Causing Chemical: Hong Kong Food Regulators Issue WarningApril 22, 2024
FTCCI organised a Workshop on Rooftop Kitchen GardeningApril 20, 2024
Children in Cities Exposed to Elevated Lead Levels: Study Reveals Urgent Health ConcernApril 20, 2024
Biocon Ventures into Weight-Loss Drug Market with Semaglutide DevelopmentApril 20, 2024
Innovative AI Assistance Empowers Moscow Doctors to Detect Cervical Spine Issues through MRI ScansApril 20, 2024
Air India Express ties up with AISATS for AeroWash Automated Aircraft Exterior Cleanings April 19, 2024
IndoSup raises strategic funding led by CCI group promoters Naresh Sharma and Satish Sharma; investors include Yatra.com’s Rohan Mittal April 19, 2024
10 compelling reasons why choosing right media platform Is important in healthcareApril 19, 2024
Protecting Public Health: Proposed Guidelines for Pharmaceutical Product DistributionApril 19, 2024
What is Haemophilia: A Genetic Bleeding Disorder that has Affected 1,36,000 IndiansApril 19, 2024
Climate Change and Stroke Risk: Exploring the Impact of Temperature Fluctuations on Your Body April 19, 2024
The Extension and Benefits of ABHA Linking with CGHS Beneficiary ID: What You Need to KnowApril 19, 2024
Mental Health Issues Impact Studies in 3 out 4 Female Students: PeakMind StudyApril 18, 2024
Atal Incubation Centre – Centre for Cellular and Molecular Biology (AIC-CCMB) signs agreement for placement of equipment with Thermo Fisher Scientific to help advance innovation in India April 18, 2024